Physician profile
Abby Rose Clinton
NPI 1932720505
$946.30
in general payments reported to CMS, 2019-2025
12 companies · $85.22 in 2025
The $85.22 reported for 2025 was less than what a typical Psychiatric/Mental Health, Child & Family provider received nationally (typical 2025 total: $178).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $566 · 2022: $35.47 · 2023: $65.57 · 2024: $194 · 2025: $85.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $166.46 | 2021-2025 | Caplyta |
| Ironshore Pharmaceuticals INC. | $166.35 | 2021-2024 | |
| Neurocrine Biosciences, INC. | $155.22 | 2021-2023 | Ingrezza |
| Abbvie INC. | $104.40 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $99.06 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $67.38 | 2024-2025 | Cobenfy |
| Tris Pharma INC | $49.89 | 2024-2025 | Dyanavel Xr |
| Lundbeck LLC | $35.08 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $33.17 | 2021-2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $25.70 | 2024 | Trintellix |
| Vertical Pharmaceuticals, LLC | $22.92 | 2024 | Relexxii |
| Sunovion Pharmaceuticals INC. | $20.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Clinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.